Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 5.6.2.2 extracted from

  • Singh, G.; Thakur, M.; Chakraborti, P.K.; Dey, C.S.
    Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile (2009), Int. J. Antimicrob. Agents, 33, 80-85.
    View publication on PubMed

Protein Variants

Protein Variants Comment Organism
R250G point mutation in the ATPase domain of topo II leading to arsenite resistance Leishmania donovani

Inhibitors

Inhibitors Comment Organism Structure
actinomycin D
-
Leishmania donovani
arsenite
-
Leishmania donovani
doxorubicin
-
Leishmania donovani
novobiocin
-
Leishmania donovani
Pentamidine
-
Leishmania donovani

Organism

Organism UniProt Comment Textmining
Leishmania donovani Q9XZN0
-
-
Leishmania donovani MHOM/80/IN/Dd8 Q9XZN0
-
-

Purification (Commentary)

Purification (Comment) Organism
partially purified Leishmania donovani

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
supercoiled DNA + ATP + H2O
-
Leishmania donovani catenated DNA networks + ADP + phosphate
-
?
supercoiled DNA + ATP + H2O
-
Leishmania donovani MHOM/80/IN/Dd8 catenated DNA networks + ADP + phosphate
-
?

Synonyms

Synonyms Comment Organism
topo II
-
Leishmania donovani
Topoisomerase II
-
Leishmania donovani

Cofactor

Cofactor Comment Organism Structure
ATP
-
Leishmania donovani